FDA Using FDA Big Data and Electronic Health Records to Improve Drug Safety Thomas Sullivan Nov 22, 2013 0 Recent research, published in the journal Science Translational Medicine, found a method to help address adverse events from…
Congress Senate Announces Open Executive Session to Discuss Repeal of SGR Thomas Sullivan Nov 21, 2013 0 Senate Finance Committee Chairman Max Baucus (D-MT) today announced an Open Executive Session on December 12th at 10am ET to…
Physician Payment Sunshine Act: Final Rule Physician Payment Sunshine Act: Open Payments Webinar CMS Avoids Hard… Thomas Sullivan Nov 21, 2013 0 The Centers for Medicare and Medicaid Services (CMS) provided two webinar sessions on Open Payments, the CMS program to implement…
Uncategorized FAQ’s on Repealing the Medical Device Tax Thomas Sullivan Nov 21, 2013 0 When we previously reported on the IRS Medical Device Tax Final Rule in January 2013, we noted that there was growing bipartisan…
CMS CMS Soliciting Comments on QHP Quality Rating System Thomas Sullivan Nov 20, 2013 0 The Centers for Medicare and Medicaid Services (CMS) issued a notice with comment yesterday, officially scheduled to be published…
CMS CMS Medicare Self-Referral Disclosure Protocol Thomas Sullivan Nov 20, 2013 0 The Centers for Medicare and Medicaid Services (CMS) published the Medicare Self-Referral Disclosure Protocol (SRDP) pursuant to…
Physician Payment Sunshine Act: Final Rule Physician Payment Sunshine Act: Open Payments May Cause Physicians to… Thomas Sullivan Nov 19, 2013 0 Under the Physician Payments Sunshine Act (Open Payments), pharmaceutical companies, medical device manufacturers, and medical…
FDA FDA Clearance of Medical Devices Through 510K (FDA and HHS-OIG Reports) Thomas Sullivan Nov 19, 2013 0 The U.S. Department of Health and Human Services, Office of Inspector General issued a report: "FDA's Clearance of Medical Devices…
International UK Sunshine Act: ABPI Updating Code of Practice to Enhance Transparency in… Thomas Sullivan Nov 18, 2013 0 Member companies of the Association of the British Pharmaceutical Industry (ABPI) have agreed to amend the ABPI Code of Practice…
FDA FDA: The Differences with Pharmaceutical and Device Promotion Standards Thomas Sullivan Nov 18, 2013 0 Over the years we have noted in our coverage of FDLI's Enforcement and Litigation Conference that DOJ and other officials…